Supplementary Tables 1 and 2. A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma.
收藏Taylor & Francis Group2024-05-15 更新2026-04-16 收录
下载链接：
https://tandf.figshare.com/articles/dataset/Supplementary_Tables_1_and_2_A_first-in-human_Phase_I_trial_of_the_oral_p-STAT3_inhibitor_WP1066_in_patients_with_recurrent_malignant_glioma_/19771747/1
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary Table 1.
Supplementary Table 2: PK Modeling Summary of WP1066 in Human Plasma
提供机构：
Majd, Nazanin K; N. Fuller, Gregory; Najem, Hinda; Sawaya, Raymond; MacDonald, Tobey J.; DeCuypere, Michael; Huse, Jason T.; Kassab, Cynthia; Priebe, Waldemar; Rao, Ganesh; Long, James P.; O’Brien, Barbara; Weathers, Shiao-Pei; de Groot, John; Fang, Dexing; Harrison, Rebecca A; Wei, Jun; Ott, Martina; Heimberger, Amy B.
创建时间：
2022-05-16
